298. Hereditary pancreatitis Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 95 / Drugs : 148 - (DrugBank : 51) / Drug target genes : 53 - Drug target pathways : 142
Drugs and their primary sponsors and trial info
A04AD10
Radboud University Nijmegen Medical Centre
2012 Phase 2 EUCTR2012-000730-19-NL Netherlands;
2011 - EUCTR2011-000647-24-NL Netherlands;
ANTOX (vers) 1.2
University of Liverpool
2008 Phase 3 EUCTR2006-000087-83-GB United Kingdom;
ANTOX (vers.)1.2
University Medicine Greifswald
2005 Phase 3 NCT00142233 Germany;
Acetyl-L-carnitine 1000mg 2X per day for 3 months
Karin High
2015 Early Phase 1 NCT02538146 United States;
Alcohol
Changhai Hospital
2011 - NCT04574297 -
Amino acids
Tohoku University Hospital
2010 - JPRN-UMIN000003020 Japan;
Amlodipine (drug)
University of Pittsburgh
2005 Phase 1/Phase 2 NCT00156403 United States;
Analgesics
Changhai Hospital
2016 - NCT02971475 China;
Antioxidant plus Pregabalin
Asian Institute of Gastroenterology, India
2012 - NCT01528540 India;
Antioxidants
All India Institute of Medical Sciences, New Delhi
2003 Phase 3 NCT00319358 India;
Antox version 1.2
Pharmanord, UK, LTD
2007 Phase 2 EUCTR2006-006958-10-GB United Kingdom;
Autologous mesenchymal stromal cell
Medical University of South Carolina
2014 Phase 1 NCT02384018 United States;
Benzoyl-L-tyrosyl-[1-13C]alanine (Bz-Tyr-Ala)
Exalenz Bioscience LTD.
2009 Phase 2 NCT01259544 India;
Bone marrow-derived mesenchymal stem cells
Medical University of South Carolina
2021 Phase 1 NCT05095532 United States;
Bupivicaine alone
The Cleveland Clinic
2008 Phase 3 NCT00658736 United States;
CREON
AbbVie
2021 Phase 4 NCT05069597 United States;
2021 - NCT04949828 United States;
2020 Phase 4 NCT04315311 United States;
Calcium, Dietary
Hvidovre University Hospital
2009 - NCT01141998 Denmark;
Carbon monoxide
Medical University of South Carolina
2015 Phase 1/Phase 2 NCT02567240 United States;
Celiac Block with triamcinolone and bupivicaine
University of Southern California
2014 - NCT02399800 United States;
Cholecalciferol
Hvidovre University Hospital
2009 - NCT01141998 Denmark;
Creon
Hospital Avicenne
2004 Phase 4 NCT00957151 France;
Institut National de la Recherche Agronomique
2005 - NCT01154608 France;
Creon 10000
Solvay Pharmaceuticals GmbH
2008 - EUCTR2007-004004-12-BG Bulgaria;
Creon 25000
Department of gastroenterology. University Hospital of Santiago
2016 - EUCTR2015-002570-20-ES Spain;
Solvay Pharmaceuticals GmbH
2008 - EUCTR2007-004004-12-BG Bulgaria;
Creon36™
Children's Hospital of Philadelphia
2016 Phase 2 NCT02849704 United States;
Diazepam
Radboud University
2011 Phase 2 NCT01318369 Netherlands;
ERCP with Bupivacaine infusion
Johns Hopkins University
2021 Early Phase 1 NCT04611958 United States;
EUR-1008 (APT-1008) High Dose
Forest Laboratories
2008 Phase 3 NCT00788593 Italy;Ukraine;United States;
EUR-1008 (APT-1008) Low Dose
Forest Laboratories
2008 Phase 3 NCT00788593 Italy;Ukraine;United States;
EUR-1066-A
Forest Laboratories
2010 Phase 1 NCT01159119 United States;
EUR-1066-B
Forest Laboratories
2010 Phase 1 NCT01159119 United States;
EUS procedure with drug injection
Centre hospitalier de l'Université de Montréal (CHUM)
2011 Phase 3 NCT01318590 Belgium;Canada;
Endoscopic drainage of the main pancreatic duct
Changhai Hospital
2016 - NCT02971475 China;
Ensure Surgical
Ohio State University
2017 - NCT03244683 United States;
Etanercept
University of Minnesota
2016 Phase 4 NCT02713997 United States;
Extracorporeal shock wave lithotripsy
Changhai Hospital
2016 - NCT02971475 China;
Extracorporeal shock wave lithotripsy and endoscopic drainage of the main pancreatic duct
Changhai Hospital
2022 - NCT05261997 China;
FLUIMUCIL*20CPR EFF
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
2012 - EUCTR2012-004170-26-IT Italy;
Gabapentin prescriptions
GlaxoSmithKline
2010 - NCT01236053 -
2010 - NCT01138124 -
Gold
The First Affiliated Hospital of the Naval Medical University of the Chinese People's Liberation Army
2020 Phase 0 ChiCTR2000037002 China;
Helopanflat Mono®
Berlin-Chemie AG
2005 - EUCTR2005-000736-24-DE Germany;
Hemoglobin
University of Nebraska
2018 - NCT03568630 United States;
Hydroxychloroquine
The Cleveland Clinic
2017 Phase 2 NCT03283566 United States;
Indomethacin
Mayo Clinic
2020 Phase 2 NCT04207060 United States;
Intra Plexus Triamcinolone and Bupivicaine Injection
University of Southern California
2014 - NCT02399800 United States;
Kreon 25000
Department of gastroenterology. University Hospital of Santiago
2016 - EUCTR2015-002570-20-ES Spain;
LANREOTIDE ACETATE
Erasme hospital
2010 - EUCTR2009-016082-29-BE Belgium;
LIPASE
Erasmus MC
2011 - EUCTR2010-020303-69-NL Netherlands;
Liprotamase
Anthera Pharmaceuticals
2007 Phase 3 NCT00500084 United States;
Lyrica
Department of Medical Gastroenterology
2008 Phase 3 EUCTR2008-002671-27-DK Denmark;
Lyrica®
Afdeling heelkunde, Universitair Medisch Centrum Sint Radboud
2009 - EUCTR2009-010266-28-NL Netherlands;
MS1819
Laboratoires Mayoly Spindler
2010 - EUCTR2010-018900-10-FR France;
MS1819-SD
AzurRx SAS
2017 Phase 2 NCT03481803 Australia;France;New Zealand;
Magnesiocard 2.5mmol
University of Liverpool
2008 Phase 3 EUCTR2006-000087-83-GB United Kingdom;
Magnesium
University Medicine Greifswald
2005 Phase 3 NCT00142233 Germany;
Mayo Interactive Breath Hold Monitor
Mayo Clinic
2006 - NCT00588367 United States;
Mezym F
Berlin-Chemie AG
2010 - EUCTR2005-000562-38-DE Germany;
Midazolam
Prof. Asbjørn Mohr Drewes
2013 Phase 4 EUCTR2013-003357-17-DK Denmark;
Morphine, buprenorphine, pethidine, tramaldol, metamizole and acetylsalicylacid (Analgesics)
Changhai Hospital
2022 - NCT05270434 China;
Multienzymes (lipase, protease etc.)
EURAND SPA
2008 - EUCTR2008-000061-37-IT Italy;
NI-03
Kangen Pharmaceuticals, Inc
2015 Phase 1/Phase 2 NCT02693093 Russian Federation;Ukraine;United States;
Namisol
Radboud University
2011 Phase 2 NCT01318369 Netherlands;
Radboud University Nijmegen Medical Centre
2012 Phase 2 EUCTR2012-000730-19-NL Netherlands;
2011 - EUCTR2011-000647-24-NL Netherlands;
Nexium (esomeprazole magnesium)
University of Florida
2009 Phase 1 NCT01142128 United States;
OXYCODONE HYDROCHLORIDE
Mech-Sense, Dept. Gastroenterology & Hepatology, Aalborg University Hospital
2017 Phase 1;Phase 4 EUCTR2017-000732-34-DK Denmark;
Omeprazole
Forest Laboratories
2007 Phase 3 NCT00559364 Canada;Germany;Poland;Slovakia;United States;
Oxycodone Depot ”Sandoz”, depot tablets
Mech-Sense, Dept. Gastroenterology & Hepatology, Aalborg University Hospital
2017 Phase 1;Phase 4 EUCTR2017-000732-34-DK Denmark;
Oxycodonhydrochlorid ”Lannacher”, depot tablets
Mech-Sense, Dept. Gastroenterology & Hepatology, Aalborg University Hospital
2017 Phase 1;Phase 4 EUCTR2017-000732-34-DK Denmark;
Oxynorm
Mech-Sense, Dept. Gastroenterology & Hepatology, Aalborg University Hospital
2017 Phase 1;Phase 4 EUCTR2017-000732-34-DK Denmark;
PFD
Yokohama City University
2017 - JPRN-UMIN000028150 Japan;
the Department of Diagnostic Radiology Kawasaki Medical School
2012 - JPRN-UMIN000008340 Japan;
PL 00512/0150
Department of gastroenterology. University Hospital of Santiago
2016 - EUCTR2015-002570-20-ES Spain;
Pancreatic enzyme(Pancreatin Enteric-coated Capsules or Oryz-Aspergillus Enzyme and Pancreatin Table), antidiabetic medicine(Acarbose Tablets, Glucophage, Glimepirde Tablets)
Changhai Hospital
2022 - NCT05261997 China;
Pancreatic enzymes
Erasmus MC
2011 - EUCTR2010-020303-69-NL Netherlands;
Pancreatin
Abbott Products
2008 Phase 3 NCT00705978 India;
Axcan Pharma S.A.
2004 - EUCTR2004-002468-89-DE Germany;
Berlin-Chemie AG
2010 - EUCTR2005-000562-38-DE Germany;
2005 - EUCTR2005-000736-24-DE Germany;
Pancrelipase
Dartmouth-Hitchcock Medical Center
2016 Phase 2 NCT02706236 United States;
Department of Internal Medicine Second Teaching Hospital Fujita Health University School of Medicine
2012 - JPRN-UMIN000009547 Japan;
Digestive Care, Inc.
2008 Phase 4 NCT00744250 United States;
Fukushima Medical University Aizu Medical Center
2013 - JPRN-UMIN000013182 Japan;
Pancrelipase Delayed Release Capsule
Solvay Pharmaceuticals GmbH
2008 - EUCTR2007-004004-12-BG Bulgaria;
Pancrelipase delayed release capsule
Solvay Pharmaceuticals
2007 Phase 3 NCT00414908 Bulgaria;Former Serbia and Montenegro;Poland;Puerto Rico;Russian Federation;Serbia;South Africa;Ukraine;United States;
Pancrelipase/Pancreas Powder
Solvay Pharmaceuticals GmbH
2008 - EUCTR2007-004004-12-BG Bulgaria;
Panzytrat
Erasmus MC
2011 - EUCTR2010-020303-69-NL Netherlands;
Panzytrat 25.000
Axcan Pharma S.A.
2004 - EUCTR2004-002468-89-DE Germany;
Panzytrat 25.000 FIP-E units of Lipase
Foundation for Liver Research
2011 Phase 4 NCT01430234 Netherlands;
Pentoxifylline
Mayo Clinic
2015 Phase 3 NCT02487225 United States;
Perflubutane
Department of EndoscopyThe Jikei University School of Medicine
2018 - JPRN-UMIN000030735 Japan;
Pioglitazone
University of Michigan
2008 Phase 2 NCT00782795 United States;
Pregabalin
Aalborg Universitetshospital
2008 Phase 2/Phase 3 NCT00755573 Denmark;Netherlands;
Department of Medical Gastroenterology
2008 Phase 3 EUCTR2008-002671-27-DK Denmark;
Prolastin-C
Medical University of South Carolina
2016 Phase 1/Phase 2 NCT02947087 United States;
Proton pump inhibitor (PPI)
Forest Laboratories
2007 Phase 3 NCT00559364 Canada;Germany;Poland;Slovakia;United States;
REGN475/SAR164877
Regeneron Pharmaceuticals
2009 Phase 2 NCT01001923 United States;
RG1068 (Synthetic Human Secretin)
Massachusetts General Hospital
2008 Phase 1 NCT00621283 United States;
2008 Phase 1 NCT00620919 United States;
RVG 13760
Erasmus MC
2011 - EUCTR2010-020303-69-NL Netherlands;
Recombinant Microbial Lipase SLV339
Solvay Pharmaceuticals
2008 Phase 2 NCT00630279 Czech Republic;Denmark;Hungary;Latvia;Poland;Russian Federation;Sweden;
Recombinant microbial lipase
Solvay Pharmaceuticals GmbH
2008 - EUCTR2007-000375-42-LV Czech Republic;Denmark;Hungary;Latvia;Sweden;
2008 - EUCTR2007-000375-42-HU Czech Republic;Denmark;Hungary;Latvia;Sweden;
2008 - EUCTR2007-000375-42-DK Czech Republic;Denmark;Hungary;Latvia;Sweden;
2008 - EUCTR2007-000375-42-CZ Czech Republic;Denmark;Hungary;Latvia;Sweden;
2007 - EUCTR2007-000375-42-SE Czech Republic;Denmark;Hungary;Latvia;Sweden;
Reparixin
Dompé Farmaceutici S.p.A
2014 Phase 2/Phase 3 NCT01967888 Canada;United States;
SA-001
Abbott
2008 Phase 3 NCT00401076 Japan;
2007 Phase 3 NCT00400842 Japan;
SLV339
Solvay Pharmaceuticals GmbH
2008 - EUCTR2007-000375-42-LV Czech Republic;Denmark;Hungary;Latvia;Sweden;
2008 - EUCTR2007-000375-42-HU Czech Republic;Denmark;Hungary;Latvia;Sweden;
2008 - EUCTR2007-000375-42-DK Czech Republic;Denmark;Hungary;Latvia;Sweden;
2008 - EUCTR2007-000375-42-CZ Czech Republic;Denmark;Hungary;Latvia;Sweden;
2007 - EUCTR2007-000375-42-SE Czech Republic;Denmark;Hungary;Latvia;Sweden;
Secretin
Children's Hospital Medical Center, Cincinnati
2016 - NCT02869893 United States;
University of Nottingham
2012 Phase 1/Phase 2 NCT02458118 United Kingdom;
2010 Phase 1 NCT01452217 United Kingdom;
Simvastatin
National Cancer Institute (NCI)
2016 Phase 2 NCT02743364 United States;
Somatuline Autogel
Erasme hospital
2010 - EUCTR2009-016082-29-BE Belgium;
Soy bread
Ohio State University
2015 - NCT02577640 United States;
Tanezumab
Pfizer
2010 Phase 2 NCT01146561 United States;
Tetrahydro-6,6,9-tri methyl-3-penthyl-6 H-dibenzo[ b,d ]pyran-1-ol
Radboud University Nijmegen Medical Centre
2012 Phase 2 EUCTR2012-000730-19-NL Netherlands;
Tetrahydrocannabinol
Radboud University
2012 Phase 2 NCT01551511 Netherlands;
Thalidomide
Winthrop University Hospital
2005 Phase 2 NCT00469703 United States;
Time interval between ESWL and ERCP is 12-36h
Changhai Hospital
2022 - NCT05270434 China;
Time interval between ESWL and ERCP is 12h
Changhai Hospital
2022 - NCT05270434 China;
Time interval between ESWL and ERCP is greater than 36h
Changhai Hospital
2022 - NCT05270434 China;
Triamcinolone
Indiana University
2002 - NCT00583271 United States;
The Cleveland Clinic
2008 Phase 3 NCT00658736 United States;
VIOKASE 16
Axcan Pharma
2008 Phase 2 NCT00559052 Czech Republic;United States;
Viokase 16 (pancrelipase) + Nexium
University of Florida
2009 Phase 1 NCT01142128 United States;
Viokase® 16
Forest Laboratories
2007 Phase 3 NCT00559364 Canada;Germany;Poland;Slovakia;United States;
Vitamin D
Tampere University Hospital
2016 - NCT02965898 Finland;
Yarrowia lipolytica lipase
Laboratoires Mayoly Spindler
2010 - EUCTR2010-018900-10-FR France;
ZENTASE
EURAND SPA
2008 - EUCTR2008-000061-37-IT Italy;
Zenpep
Forest Laboratories
2010 Phase 1 NCT01159119 United States;
dehydrated alcohol
Indiana University
2002 - NCT00583271 United States;
Radboud University Nijmegen Medical Centre
2012 Phase 2 EUCTR2012-000730-19-NL Netherlands;
2011 - EUCTR2011-000647-24-NL Netherlands;
ANTOX (vers) 1.2
University of Liverpool
2008 Phase 3 EUCTR2006-000087-83-GB United Kingdom;
ANTOX (vers.)1.2
University Medicine Greifswald
2005 Phase 3 NCT00142233 Germany;
Acetyl-L-carnitine 1000mg 2X per day for 3 months
Karin High
2015 Early Phase 1 NCT02538146 United States;
Alcohol
Changhai Hospital
2011 - NCT04574297 -
Amino acids
Tohoku University Hospital
2010 - JPRN-UMIN000003020 Japan;
Amlodipine (drug)
University of Pittsburgh
2005 Phase 1/Phase 2 NCT00156403 United States;
Analgesics
Changhai Hospital
2016 - NCT02971475 China;
Antioxidant plus Pregabalin
Asian Institute of Gastroenterology, India
2012 - NCT01528540 India;
Antioxidants
All India Institute of Medical Sciences, New Delhi
2003 Phase 3 NCT00319358 India;
Antox version 1.2
Pharmanord, UK, LTD
2007 Phase 2 EUCTR2006-006958-10-GB United Kingdom;
Autologous mesenchymal stromal cell
Medical University of South Carolina
2014 Phase 1 NCT02384018 United States;
Benzoyl-L-tyrosyl-[1-13C]alanine (Bz-Tyr-Ala)
Exalenz Bioscience LTD.
2009 Phase 2 NCT01259544 India;
Bone marrow-derived mesenchymal stem cells
Medical University of South Carolina
2021 Phase 1 NCT05095532 United States;
Bupivicaine alone
The Cleveland Clinic
2008 Phase 3 NCT00658736 United States;
CREON
AbbVie
2021 Phase 4 NCT05069597 United States;
2021 - NCT04949828 United States;
2020 Phase 4 NCT04315311 United States;
Calcium, Dietary
Hvidovre University Hospital
2009 - NCT01141998 Denmark;
Carbon monoxide
Medical University of South Carolina
2015 Phase 1/Phase 2 NCT02567240 United States;
Celiac Block with triamcinolone and bupivicaine
University of Southern California
2014 - NCT02399800 United States;
Cholecalciferol
Hvidovre University Hospital
2009 - NCT01141998 Denmark;
Creon
Hospital Avicenne
2004 Phase 4 NCT00957151 France;
Institut National de la Recherche Agronomique
2005 - NCT01154608 France;
Creon 10000
Solvay Pharmaceuticals GmbH
2008 - EUCTR2007-004004-12-BG Bulgaria;
Creon 25000
Department of gastroenterology. University Hospital of Santiago
2016 - EUCTR2015-002570-20-ES Spain;
Solvay Pharmaceuticals GmbH
2008 - EUCTR2007-004004-12-BG Bulgaria;
Creon36™
Children's Hospital of Philadelphia
2016 Phase 2 NCT02849704 United States;
Diazepam
Radboud University
2011 Phase 2 NCT01318369 Netherlands;
ERCP with Bupivacaine infusion
Johns Hopkins University
2021 Early Phase 1 NCT04611958 United States;
EUR-1008 (APT-1008) High Dose
Forest Laboratories
2008 Phase 3 NCT00788593 Italy;Ukraine;United States;
EUR-1008 (APT-1008) Low Dose
Forest Laboratories
2008 Phase 3 NCT00788593 Italy;Ukraine;United States;
EUR-1066-A
Forest Laboratories
2010 Phase 1 NCT01159119 United States;
EUR-1066-B
Forest Laboratories
2010 Phase 1 NCT01159119 United States;
EUS procedure with drug injection
Centre hospitalier de l'Université de Montréal (CHUM)
2011 Phase 3 NCT01318590 Belgium;Canada;
Endoscopic drainage of the main pancreatic duct
Changhai Hospital
2016 - NCT02971475 China;
Ensure Surgical
Ohio State University
2017 - NCT03244683 United States;
Etanercept
University of Minnesota
2016 Phase 4 NCT02713997 United States;
Extracorporeal shock wave lithotripsy
Changhai Hospital
2016 - NCT02971475 China;
Extracorporeal shock wave lithotripsy and endoscopic drainage of the main pancreatic duct
Changhai Hospital
2022 - NCT05261997 China;
FLUIMUCIL*20CPR EFF
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
2012 - EUCTR2012-004170-26-IT Italy;
Gabapentin prescriptions
GlaxoSmithKline
2010 - NCT01236053 -
2010 - NCT01138124 -
Gold
The First Affiliated Hospital of the Naval Medical University of the Chinese People's Liberation Army
2020 Phase 0 ChiCTR2000037002 China;
Helopanflat Mono®
Berlin-Chemie AG
2005 - EUCTR2005-000736-24-DE Germany;
Hemoglobin
University of Nebraska
2018 - NCT03568630 United States;
Hydroxychloroquine
The Cleveland Clinic
2017 Phase 2 NCT03283566 United States;
Indomethacin
Mayo Clinic
2020 Phase 2 NCT04207060 United States;
Intra Plexus Triamcinolone and Bupivicaine Injection
University of Southern California
2014 - NCT02399800 United States;
Kreon 25000
Department of gastroenterology. University Hospital of Santiago
2016 - EUCTR2015-002570-20-ES Spain;
LANREOTIDE ACETATE
Erasme hospital
2010 - EUCTR2009-016082-29-BE Belgium;
LIPASE
Erasmus MC
2011 - EUCTR2010-020303-69-NL Netherlands;
Liprotamase
Anthera Pharmaceuticals
2007 Phase 3 NCT00500084 United States;
Lyrica
Department of Medical Gastroenterology
2008 Phase 3 EUCTR2008-002671-27-DK Denmark;
Lyrica®
Afdeling heelkunde, Universitair Medisch Centrum Sint Radboud
2009 - EUCTR2009-010266-28-NL Netherlands;
MS1819
Laboratoires Mayoly Spindler
2010 - EUCTR2010-018900-10-FR France;
MS1819-SD
AzurRx SAS
2017 Phase 2 NCT03481803 Australia;France;New Zealand;
Magnesiocard 2.5mmol
University of Liverpool
2008 Phase 3 EUCTR2006-000087-83-GB United Kingdom;
Magnesium
University Medicine Greifswald
2005 Phase 3 NCT00142233 Germany;
Mayo Interactive Breath Hold Monitor
Mayo Clinic
2006 - NCT00588367 United States;
Mezym F
Berlin-Chemie AG
2010 - EUCTR2005-000562-38-DE Germany;
Midazolam
Prof. Asbjørn Mohr Drewes
2013 Phase 4 EUCTR2013-003357-17-DK Denmark;
Morphine, buprenorphine, pethidine, tramaldol, metamizole and acetylsalicylacid (Analgesics)
Changhai Hospital
2022 - NCT05270434 China;
Multienzymes (lipase, protease etc.)
EURAND SPA
2008 - EUCTR2008-000061-37-IT Italy;
NI-03
Kangen Pharmaceuticals, Inc
2015 Phase 1/Phase 2 NCT02693093 Russian Federation;Ukraine;United States;
Namisol
Radboud University
2011 Phase 2 NCT01318369 Netherlands;
Radboud University Nijmegen Medical Centre
2012 Phase 2 EUCTR2012-000730-19-NL Netherlands;
2011 - EUCTR2011-000647-24-NL Netherlands;
Nexium (esomeprazole magnesium)
University of Florida
2009 Phase 1 NCT01142128 United States;
OXYCODONE HYDROCHLORIDE
Mech-Sense, Dept. Gastroenterology & Hepatology, Aalborg University Hospital
2017 Phase 1;Phase 4 EUCTR2017-000732-34-DK Denmark;
Omeprazole
Forest Laboratories
2007 Phase 3 NCT00559364 Canada;Germany;Poland;Slovakia;United States;
Oxycodone Depot ”Sandoz”, depot tablets
Mech-Sense, Dept. Gastroenterology & Hepatology, Aalborg University Hospital
2017 Phase 1;Phase 4 EUCTR2017-000732-34-DK Denmark;
Oxycodonhydrochlorid ”Lannacher”, depot tablets
Mech-Sense, Dept. Gastroenterology & Hepatology, Aalborg University Hospital
2017 Phase 1;Phase 4 EUCTR2017-000732-34-DK Denmark;
Oxynorm
Mech-Sense, Dept. Gastroenterology & Hepatology, Aalborg University Hospital
2017 Phase 1;Phase 4 EUCTR2017-000732-34-DK Denmark;
PFD
Yokohama City University
2017 - JPRN-UMIN000028150 Japan;
the Department of Diagnostic Radiology Kawasaki Medical School
2012 - JPRN-UMIN000008340 Japan;
PL 00512/0150
Department of gastroenterology. University Hospital of Santiago
2016 - EUCTR2015-002570-20-ES Spain;
Pancreatic enzyme(Pancreatin Enteric-coated Capsules or Oryz-Aspergillus Enzyme and Pancreatin Table), antidiabetic medicine(Acarbose Tablets, Glucophage, Glimepirde Tablets)
Changhai Hospital
2022 - NCT05261997 China;
Pancreatic enzymes
Erasmus MC
2011 - EUCTR2010-020303-69-NL Netherlands;
Pancreatin
Abbott Products
2008 Phase 3 NCT00705978 India;
Axcan Pharma S.A.
2004 - EUCTR2004-002468-89-DE Germany;
Berlin-Chemie AG
2010 - EUCTR2005-000562-38-DE Germany;
2005 - EUCTR2005-000736-24-DE Germany;
Pancrelipase
Dartmouth-Hitchcock Medical Center
2016 Phase 2 NCT02706236 United States;
Department of Internal Medicine Second Teaching Hospital Fujita Health University School of Medicine
2012 - JPRN-UMIN000009547 Japan;
Digestive Care, Inc.
2008 Phase 4 NCT00744250 United States;
Fukushima Medical University Aizu Medical Center
2013 - JPRN-UMIN000013182 Japan;
Pancrelipase Delayed Release Capsule
Solvay Pharmaceuticals GmbH
2008 - EUCTR2007-004004-12-BG Bulgaria;
Pancrelipase delayed release capsule
Solvay Pharmaceuticals
2007 Phase 3 NCT00414908 Bulgaria;Former Serbia and Montenegro;Poland;Puerto Rico;Russian Federation;Serbia;South Africa;Ukraine;United States;
Pancrelipase/Pancreas Powder
Solvay Pharmaceuticals GmbH
2008 - EUCTR2007-004004-12-BG Bulgaria;
Panzytrat
Erasmus MC
2011 - EUCTR2010-020303-69-NL Netherlands;
Panzytrat 25.000
Axcan Pharma S.A.
2004 - EUCTR2004-002468-89-DE Germany;
Panzytrat 25.000 FIP-E units of Lipase
Foundation for Liver Research
2011 Phase 4 NCT01430234 Netherlands;
Pentoxifylline
Mayo Clinic
2015 Phase 3 NCT02487225 United States;
Perflubutane
Department of EndoscopyThe Jikei University School of Medicine
2018 - JPRN-UMIN000030735 Japan;
Pioglitazone
University of Michigan
2008 Phase 2 NCT00782795 United States;
Pregabalin
Aalborg Universitetshospital
2008 Phase 2/Phase 3 NCT00755573 Denmark;Netherlands;
Department of Medical Gastroenterology
2008 Phase 3 EUCTR2008-002671-27-DK Denmark;
Prolastin-C
Medical University of South Carolina
2016 Phase 1/Phase 2 NCT02947087 United States;
Proton pump inhibitor (PPI)
Forest Laboratories
2007 Phase 3 NCT00559364 Canada;Germany;Poland;Slovakia;United States;
REGN475/SAR164877
Regeneron Pharmaceuticals
2009 Phase 2 NCT01001923 United States;
RG1068 (Synthetic Human Secretin)
Massachusetts General Hospital
2008 Phase 1 NCT00621283 United States;
2008 Phase 1 NCT00620919 United States;
RVG 13760
Erasmus MC
2011 - EUCTR2010-020303-69-NL Netherlands;
Recombinant Microbial Lipase SLV339
Solvay Pharmaceuticals
2008 Phase 2 NCT00630279 Czech Republic;Denmark;Hungary;Latvia;Poland;Russian Federation;Sweden;
Recombinant microbial lipase
Solvay Pharmaceuticals GmbH
2008 - EUCTR2007-000375-42-LV Czech Republic;Denmark;Hungary;Latvia;Sweden;
2008 - EUCTR2007-000375-42-HU Czech Republic;Denmark;Hungary;Latvia;Sweden;
2008 - EUCTR2007-000375-42-DK Czech Republic;Denmark;Hungary;Latvia;Sweden;
2008 - EUCTR2007-000375-42-CZ Czech Republic;Denmark;Hungary;Latvia;Sweden;
2007 - EUCTR2007-000375-42-SE Czech Republic;Denmark;Hungary;Latvia;Sweden;
Reparixin
Dompé Farmaceutici S.p.A
2014 Phase 2/Phase 3 NCT01967888 Canada;United States;
SA-001
Abbott
2008 Phase 3 NCT00401076 Japan;
2007 Phase 3 NCT00400842 Japan;
SLV339
Solvay Pharmaceuticals GmbH
2008 - EUCTR2007-000375-42-LV Czech Republic;Denmark;Hungary;Latvia;Sweden;
2008 - EUCTR2007-000375-42-HU Czech Republic;Denmark;Hungary;Latvia;Sweden;
2008 - EUCTR2007-000375-42-DK Czech Republic;Denmark;Hungary;Latvia;Sweden;
2008 - EUCTR2007-000375-42-CZ Czech Republic;Denmark;Hungary;Latvia;Sweden;
2007 - EUCTR2007-000375-42-SE Czech Republic;Denmark;Hungary;Latvia;Sweden;
Secretin
Children's Hospital Medical Center, Cincinnati
2016 - NCT02869893 United States;
University of Nottingham
2012 Phase 1/Phase 2 NCT02458118 United Kingdom;
2010 Phase 1 NCT01452217 United Kingdom;
Simvastatin
National Cancer Institute (NCI)
2016 Phase 2 NCT02743364 United States;
Somatuline Autogel
Erasme hospital
2010 - EUCTR2009-016082-29-BE Belgium;
Soy bread
Ohio State University
2015 - NCT02577640 United States;
Tanezumab
Pfizer
2010 Phase 2 NCT01146561 United States;
Tetrahydro-6,6,9-tri methyl-3-penthyl-6 H-dibenzo[ b,d ]pyran-1-ol
Radboud University Nijmegen Medical Centre
2012 Phase 2 EUCTR2012-000730-19-NL Netherlands;
Tetrahydrocannabinol
Radboud University
2012 Phase 2 NCT01551511 Netherlands;
Thalidomide
Winthrop University Hospital
2005 Phase 2 NCT00469703 United States;
Time interval between ESWL and ERCP is 12-36h
Changhai Hospital
2022 - NCT05270434 China;
Time interval between ESWL and ERCP is 12h
Changhai Hospital
2022 - NCT05270434 China;
Time interval between ESWL and ERCP is greater than 36h
Changhai Hospital
2022 - NCT05270434 China;
Triamcinolone
Indiana University
2002 - NCT00583271 United States;
The Cleveland Clinic
2008 Phase 3 NCT00658736 United States;
VIOKASE 16
Axcan Pharma
2008 Phase 2 NCT00559052 Czech Republic;United States;
Viokase 16 (pancrelipase) + Nexium
University of Florida
2009 Phase 1 NCT01142128 United States;
Viokase® 16
Forest Laboratories
2007 Phase 3 NCT00559364 Canada;Germany;Poland;Slovakia;United States;
Vitamin D
Tampere University Hospital
2016 - NCT02965898 Finland;
Yarrowia lipolytica lipase
Laboratoires Mayoly Spindler
2010 - EUCTR2010-018900-10-FR France;
ZENTASE
EURAND SPA
2008 - EUCTR2008-000061-37-IT Italy;
Zenpep
Forest Laboratories
2010 Phase 1 NCT01159119 United States;
dehydrated alcohol
Indiana University
2002 - NCT00583271 United States;